Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

NCT04973280 · clinicaltrials.gov ↗
COMPLETED
Status
187
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Celgene